03.01.17
Press Release
Achieve Life Science and OncoGenex Pharmaceuticals Announce Strategic Collaboration with the National Institutes of Health to Advance the Development of Cytisine for Smoking Cessation
March 1, 2017 Ongoing IND-enabling Non-clinical Program to Support the Use of Cytisine in Smoking Cessation Multiple Key Cytisine Development and Regulatory Milestones Expected in 2017 MILL VALLEY, Calif., BOTHELL, Wash. and VANCOUVER, British Columbia, March 1, 2017 /CNW/ — Achieve Life Science, Inc. (Achieve) and OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) (OncoGenex) today announced a…
/Read More